Ken Griffin Optimize Rx Corp Transaction History
Citadel Advisors LLC
- $505 Billion
- Q3 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Optimize Rx Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 800 shares of OPRX stock, worth $3,247. This represents 0.0% of its overall portfolio holdings.
Number of Shares
800
Previous 21,800
96.33%
Holding current value
$3,247
Previous $218,000
97.25%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding OPRX
# of Institutions
89Shares Held
12.1MCall Options Held
800Put Options Held
18.1K-
First Light Asset Management, LLC Edina, MN1.81MShares$7.36 Million1.22% of portfolio
-
Black Rock Inc. New York, NY1.18MShares$4.77 Million0.0% of portfolio
-
Awm Investment Company, Inc. New York, NY1.07MShares$4.35 Million1.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA953KShares$3.87 Million0.0% of portfolio
-
Blair William & CO Chicago, IL677KShares$2.75 Million0.02% of portfolio
About OptimizeRx Corp
- Ticker OPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 18,023,100
- Market Cap $73.2M
- Description
- OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patien...